Publication: Intravenous Quinidine for the Treatment of Severe falciparum Malaria: Clinical and Pharmacokinetic Studies
Issued Date
1985-05-16
Resource Type
ISSN
15334406
00284793
00284793
Other identifier(s)
2-s2.0-0021858738
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
New England Journal of Medicine. Vol.312, No.20 (1985), 1273-1278
Suggested Citation
Rodney E. Phillips, David A. Warrell, Nicholas J. White, Sornchai Looareesuwan, Juntra Karbwang Intravenous Quinidine for the Treatment of Severe falciparum Malaria: Clinical and Pharmacokinetic Studies. New England Journal of Medicine. Vol.312, No.20 (1985), 1273-1278. doi:10.1056/NEJM198505163122001 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/30867
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Intravenous Quinidine for the Treatment of Severe falciparum Malaria: Clinical and Pharmacokinetic Studies
Other Contributor(s)
Abstract
Over 100 years ago, quinidine, a cinchona alkaloid, was found to be effective against Plasmodium falciparum malaria in India.1Later investigations in Malaya,2Louisiana,3and New York4produced evidence that quinidine was as effective as quinine as an antimalarial agent and possibly superior to it. The success of synthetic drugs, particularly chloroquine, overshadowed interest in defining the potency of cinchona alkaloids used singly and in combination for the treatment of malaria. However, there are now urgent reasons for reviving this discussion. First of all, in Southeast Asia, P. falciparum is becoming resistant to all available antimalarial agents, including quinine, yet. © 1985, Massachusetts Medical Society. All rights reserved.